Paul A. Gurbel
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management 112
- Cardiology and Cardiovascular Medicine top 0.05%
- Antiplatelet Therapy and Cardiovascular Diseases 276
- Acute Myocardial Infarction Research 141
- Atrial Fibrillation Management and Outcomes 82
- Surgery top 0.1%
- Coronary Interventions and Diagnostics 103
- Lipoproteins and Cardiovascular Health 58
- Hematology top 0.5%
- Pharmacology top 0.2%
- Inflammatory mediators and NSAID effects 31
-
- Cardiac Imaging and Diagnostics 24
- Co-authors
- Udaya S. TantryKevin P. BlidenChristopher M. O’ConnorBonnie L. HiattMark J. AntoninoJoseph DiChiaraRobert F. StoreyKevin Hayes
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Paul A. Gurbel
405 papers receiving 17.3k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Internal Medicine 4.5k
- Cardiology and Cardiovascular Medicine 14.1k
- Surgery 8.0k
- Hematology 1.3k
- Pharmacology 1.9k
Countries citing papers authored by Paul A. Gurbel
This map shows the geographic impact of Paul A. Gurbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Gurbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Gurbel more than expected).
Fields of papers citing papers by Paul A. Gurbel
This network shows the impact of papers produced by Paul A. Gurbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Gurbel. The network helps show where Paul A. Gurbel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul A. Gurbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 25 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 14 | |
| 15 | 2020 | 21 | |
| 16 | 2019 | 51 | |
| 17 | 2019 | 54 | |
| 18 | 2013 | 2 | |
| 19 | Abstract 15997: First Report of a Dose Dependent Effect of Statin Therapy on Urinary 11-dehydrothromboxane Br2 rLevels: A New Marker for Personalizing Statin Therapy | 2012 | 1 |
| 20 | Abstract 5901: The Effect of Ticagrelor in Stable Coronary Artery Disease Patients Nonresponsive to Clopidogrel: The RESPOND Study | 2009 | 3 |
About Paul A. Gurbel
Paul A. Gurbel is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery, having authored 419 papers that have together received 17.7k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (276 papers), Acute Myocardial Infarction Research (141 papers), Venous Thromboembolism Diagnosis and Management (112 papers), Coronary Interventions and Diagnostics (103 papers), Atrial Fibrillation Management and Outcomes (82 papers), Lipoproteins and Cardiovascular Health (58 papers), Inflammatory mediators and NSAID effects (31 papers) and Cardiac Imaging and Diagnostics (24 papers). The work is most often cited by research in Internal Medicine (4.5k citations), Cardiology and Cardiovascular Medicine (14.1k citations) and Surgery (8.0k citations). Paul A. Gurbel has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Udaya S. Tantry, Kevin P. Bliden, Christopher M. O’Connor, Bonnie L. Hiatt, Mark J. Antonino, Udaya S. Tantry, Joseph DiChiara, Robert F. Storey, Kevin Hayes and Victor L. Serebruany. Their work appears in journals such as The Lancet, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.